期刊名称：BIOTECHNOLOGY FOR BIOFUELS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Biotechnology for Biofuels is an open access, peer-reviewed online journal featuring high-quality studies describing technological and operational advances in the production of biofuels from biomass.
Biotechnology for Biofuels emphasizes understanding and advancing the application of biotechnology and synergistic operations to improve plants and biological conversion systems for the production of fuels from lignocellulosic biomass and any related economic, environmental and policy issues.
Biotechnology for Biofuels focuses on the following areas:
Development of plants for biofuels production
Plant deconstruction
Pretreatment and fractionation
Enzyme production and enzymatic conversion
Fermentation and bioconversion
Integrated systems
Process design and economics
Life cycle studies
Content overview
Biotechnology for Biofuels considers the following types of articles:
Research: reports of data from original research. These articles will form the major content of the journal.
Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal.
Commentaries: short, focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board.
Methodology articles: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. Methodology articles will only be accepted for publication if they represent a significant advance in the field.
Peer-review policies
Manuscripts will be reviewed by internationally recognized experts in the field, selected in part from our Editorial Board. Reviews will be rapid and the suitability of a manuscript for publication will be assessed solely on criteria of scientific excellence. Final decisions will be made by the Editors-in-Chief.
Edited by Bärbel Hahn-Hägerdal, Michael Himmel and Charles Wyman, Biotechnology for Biofuels is supported by an expert Editorial Board.
Publishing in Biotechnology for Biofuels
All articles are listed in PubMed immediately upon acceptance (after peer review), and are covered by PubMed Central, Thomson Reuters (ISI), CAS, CABI and Scopus.
Articles in Biotechnology for Biofuels should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.
Instructions to Authors
Submission process
Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The submitting author takes responsibility for the article during submission and peer review.
To facilitate rapid publication and to minimize administrative costs, Biotechnology for Biofuels accepts only online submission.
Files can be submitted as a batch, or one by one. The submission process can be interrupted at any time - when users return to the site, they can carry on where they left off.
See below for examples of acceptable word processor and graphics file formats. Additional files of any type, such as movies, animations, or original data files, can also be submitted as part of the publication.
During submission you will be asked to provide a cover letter. Please use this to explain why your manuscript should be published in the journal and to elaborate on any issues relating to our editorial policies detailed in the instructions for authors.
Assistance with the process of manuscript preparation and submission is available from the customer support team (info@biomedcentral.com).
We also provide a collection of links to useful tools and resources for scientific authors, on our Tools for Authors page.
Publication and peer review processes
Biotechnology for Biofuels uses online peer review to speed up the publication process. The time taken to reach a final decision depends on whether reviewers request revisions, and how quickly authors are able to respond.
Once an article is accepted, it is published in Biotechnology for Biofuels immediately as a provisional PDF file. The paper will subsequently be published in both fully browseable web form, and as a formatted PDF. The article will then be available through Biotechnology for Biofuels, BioMed Central and PubMed Central, and will also be included in PubMed.
The ultimate responsibility for any decision lies with the Editor-in-Chief, to whom any appeals against rejection should be addressed.
Article-processing charges
Biotechnology for Biofuels levies an article-processing charge for every accepted article, to cover the costs incurred by open access publication. In 2010 the article-processing charge is £1255/US$2025/€1455. Generally, if the submitting author's institution is a BioMed Central member the cost of the article processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are supporter members of BioMed Central, however, a discounted article processing charge is payable by the author. Please click here to check if your institution is a BioMed Central member. Waivers may be granted, particularly for authors from developing countries. For further details, see more information about article-processing charges.
Editorial policies
Any manuscripts, or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. The journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and stated in the abstract. Further information on duplicate/overlapping publications can be found here. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who publish in Biotechnology for Biofuels retain copyright to their work (more information). Correspondence concerning articles published in Biotechnology for Biofuels is encouraged.
Submission of a manuscript to Biotechnology for Biofuels implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Research carried out on humans must be in compliance with the Helsinki Declaration, and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained.
Biotechnology for Biofuels's publisher, BioMed Central, has a legal responsibility to ensure that its journals do not publish material that infringes copyright, or that includes libellous or defamatory content. If, on review, your manuscript is perceived to contain potentially libellous content the journal Editors, with assistance from the publisher if required, will work with authors to ensure an appropriate outcome is reached.
Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.
We ask authors of Biotechnology for Biofuels papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, to follow the Acknowledgements. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Much has been written about competing interests (or conflict of interest, as other journals call it) within scientific research, but the following articles provide some background:
R Smith: Beyond conflict of interest. BMJ 1998, 317 :291-292
R Smith: Making progress with competing interests. BMJ 2002, 325 :1375-1376
CD DeAngelis, PB Fontanarosa, A Flanagin: Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001, 286 :89-9
K Morin, H Rakatansky, FA Riddick Jr, LJ Morse, JM O'Bannon 3rd, MS Goldrich, P Ray, M Weiss, RM Sade, MA Spillman: Managing conflicts of interest in the conduct of clinical trials. JAMA 2002, 287 :78-84
Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.
Submission of a manuscript to Biotechnology for Biofuels implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.
Biotechnology for Biofuels also supports initiatives aimed at improving the reporting of biomedical research. We recommend authors refer to the MIBBI Portal for prescriptive checklists for reporting biological and biomedical research where applicable.
Nucleotide sequences
Nucleotide sequences can be deposited with the DNA Data Bank of Japan (DDBJ), European Molecular Biology Laboratory (EMBL/EBI) Nucleotide Sequence Database, or GenBank (National Center for Biotechnology Information).
Protein sequences
Protein sequences can be deposited with SwissProt or the Protein Information Resource (PIR).
Structures
Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank. Nucleic Acids structures can be deposited with the Nucleic Acid Database at Rutgers. Crystal structures of organic compounds can be deposited with the Cambridge Crystallographic Data Centre.
Chemical structures and assays
Structures of chemical substances can be deposited with PubChem Substance. Bioactivity screens of chemical substances can be deposited with PubChem BioAssay.
Microarray data
Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society and must deposit microarray data in one of the public repositories, such as ArrayExpress, Gene Expression Omnibus (GEO) or the Center for Information Biology Gene Expression Database (CIBEX).
Computional modeling
We encourage authors to prepare models of biochemical reaction networks using the Systems Biology Markup Language and to deposit the model with the BioModels database, as well as submitting it as an additional file with the manuscript.
Plasmids
We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with Addgene, a non-profit repository, or PlasmID, the Plasmid Information Database at Harvard.
BioMed Central is a member of the Committee on Publication Ethics (COPE). Authors who have appealed against a rejection but remain concerned about the editorial process can refer their case to COPE. For more information, visit www.publicationethics.org.
BioMed Central endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions.
File formats
The following word processor file formats are acceptable for the main manuscript document:
Microsoft Word (version 2 and above)
Rich text format (RTF)
Portable document format (PDF)
TeX/LaTeX (use BioMed Central's TeX template)
DeVice Independent format (DVI)
Publicon Document (NB)
Users of other word processing packages should save or convert their files to RTF before uploading. Many free tools are available which ease this process.
TeX/LaTeX users: We recommend using BioMed Central's TeX template and BibTeX stylefile. If you use this standard format, you can submit your manuscript in TeX format (after you submit your TEX file, you will be prompted to submit your BBL file). If you have used another template for your manuscript, or if you do not wish to use BibTeX, then please submit your manuscript as a DVI file. We do not recommend converting to RTF.
Note that figures must be submitted as separate image files, not as part of the submitted DOC/ PDF/TEX/DVI file.
Article types
When submitting your manuscript, you will be asked to assign one of the following types to your article:
Please read the descriptions of each of the article types, choose which is appropriate for your article and structure it accordingly. If in doubt, your manuscript should be classified as Research, the structure for which is described below.
Manuscript sections for Research articles
Manuscripts for Research articles submitted to Biotechnology for Biofuels should be divided into the following sections:
Title page
Abstract
Background
Results
Discussion
Conclusions
Methods (can also be placed after Background)
List of abbreviations used(if any)
Competing interests
Authors' contributions
Authors' information (if any)
Acknowledgements and Funding
References
Figure legends (if any)
Tables and captions (if any)
Description of additional data files (if any)
You can download a template (Mac and Windows compatible; Microsoft Word 98/2000) for your article. For instructions on use, see below.
The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].
The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein Database (Swiss-Prot).
Title page
This should list: the title of the article, which should include an accurate, clear and concise description of the reported work, avoiding abbreviations; and the full names, institutional addresses, and e-mail addresses for all authors. The corresponding author should also be indicated.
Abstract
The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context and purpose of the study; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract.
Background
The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. The section should end with a very brief statement of what is being reported in the article.
Results and Discussion
The Results and Discussion may be combined into a single section or presented separately. They may also be broken into subsections with short, informative headings.
Conclusions
This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.
Methods
This should be divided into subsections if several methods are described.
List of abbreviations
If abbreviations are used in the text, either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests and authors' contributions.
Competing interests
A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.
Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.
When completing your declaration, please consider the following questions:
Financial competing interests
In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.
Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.
Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.
Do you have any other financial competing interests? If so, please specify.
Non-financial competing interests
Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.
If you are unsure as to whether you or one of your co-authors has a competing interest, please discuss it with the editorial office.
Authors' contributions
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.
An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
We suggest the following kind of format (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.
Authors' information
You may choose to use this section to include any relevant information about the author(s) that may aid the reader’s interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.
Acknowledgements and Funding
Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.
Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
References
All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.
Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text and referred to as "unpublished data", "unpublished observations", or "personal communications" giving the names of the involved researchers. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.
Examples of the Biotechnology for Biofuels reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading.
Links
Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do]
Biotechnology for Biofuels reference style
Style files are available for use with popular bibliographic management software:
BibTeX
EndNote style file
Reference Manager
Zotero
Article within a journal
1. Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat Genet 1996, 13:266-267.
Article within a journal supplement
2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, 43(Suppl 3):149-170.
In press article
3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press.
Published abstract
4. Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999, 42:s250.
Article within conference proceedings
5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.
Book chapter, or article within a book
6. Schnepf E: From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76.
Whole issue of journal
7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72.
Whole conference proceedings
8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.
Complete book
9. Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970.
Monograph or book in a series
10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vol 1.]
Book with institutional author
11. Advisory Committee on Genetic Modification: Annual Report. London; 1999.
PhD thesis
12. Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. Stanford University, Computer Science Department; 1995.
Link / URL
13. The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do]
Microsoft Word template
Although we can accept manuscripts prepared as Microsoft Word, RTF or PDF files, we have designed a Microsoft Word template that can be used to generate a standard style and format for your article. It can be used if you have not yet started to write your paper, or if it is already written and needs to be put into Biotechnology for Biofuels style.
Download the template (compatible with Mac and Windows Word 97/98/2000/2003/2007) from our site, and save it to your hard drive. Double click the template to open it.
How to use the Biotechnology for Biofuels template
The template consists of a standard set of headings that make up a Biotechnology for Biofuels Research manuscript, along with dummy fragments of body text. Follow these steps to create your manuscript in the standard format:
Replace the dummy text for Title, Author details, Institutional affiliations, and the other sections of the manuscript with your own text (either by entering the text directly or by cutting and pasting from your own manuscript document).
If there are sections which you do not need, delete them (but check the rest of the Instructions for Authors to see which sections are compulsory).
If you need an additional copy of a heading (e.g. for additional figure legends) just copy and paste.
For the references, you may either manually enter the references using the reference style given, or use bibliographic software to insert them automatically. We provide style files for EndNote, Reference Manager and Zotero.
For extra convenience, you can use the template as one of your standard Word templates. To do this, put a copy of the template file in Word's 'Templates' folder, normally C:\Program Files\Microsoft Office\Templates on a PC. The next time you create a new document in Word using the File menu, the template will appear as one of the available choices for a new document.
Editorial Board
Editors-in-Chief
Bärbel Hahn-Hägerdal (Sweden)
Michael Himmel (United States)
Charles Wyman (United States)
Associate Editors
Robert Anex (United States)
Edward A. Bayer (Israel)
Clint Chapple (United States)
James C. du Preez (South Africa)
Jean-Marie Francois (France)
James D. McMillan (United States)
Stephen Moose (United States)
Lisbeth Olsson (Sweden)
Philippe Soucaille (France)
Gail Taylor (United Kingdom)
David Wilson (United States)
Guido Zacchi (Sweden)
Editorial Board
Andy Aden (United States)
Elba P.S. Bon (Brazil)
Harry Brumer (Sweden)
Debabrata Das (India)
Bruce Dien (United States)
Shi-You Ding (United States)
Jaime Finguerut (Brazil)
Johann Görgens (South Africa)
Susan M. Hennessey (United States)
David K. Johnson (United States)
Martin Keller (United States)
Akihiko Kondo (Japan)
Rajeev Kumar (United States)
Mike Ladisch (United States)
Y. Y. Lee (United States)
Gunnar Liden (Sweden)
Warren Mabee (Canada)
Ana Souto Maior (Brazil)
John Manners (Australia)
Jonathan Mielenz (United States)
Colin Mitchinson (United States)
Debra Mohnen (United States)
Nate Mosier (United States)
Quang Nguyen (United States)
Lars J. Nilsson (Sweden)
Joy Doran Peterson (United States)
Paul Roessler (United States)
Peter Rogers (Australia)
Jack Saddler (Canada)
Steven R. Thomas (United States)
Anthony Turhollow (United States)
Gerald A. Tuskan (United States)
Ed van Niel (Sweden)
W.H. van Zyl (South Africa)
Liisa Viikari (Finland)
Sune Wännström (Sweden)
Seiya Watanabe (Japan)
Paul Weimer (United States)
James Zhang (United States)
Y.-H. Percival Zhang (United States)
| 
刊名字顺( Alphabetical List of Journals):
返回页首 